Annual D&A
$2.06 M
-$156.00 K-7.04%
December 31, 2022
Summary
- As of February 8, 2025, EVLO annual depreciation & amortization is $2.06 million, with the most recent change of -$156.00 thousand (-7.04%) on December 31, 2022.
- During the last 3 years, EVLO annual D&A has risen by +$296.00 thousand (+16.78%).
- EVLO annual D&A is now -7.04% below its all-time high of $2.22 million, reached on December 31, 2021.
Performance
EVLO Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$169.00 K
-$255.00 K-60.14%
September 30, 2023
Summary
- As of February 8, 2025, EVLO quarterly depreciation & amortization is $169.00 thousand, with the most recent change of -$255.00 thousand (-60.14%) on September 30, 2023.
- Over the past year, EVLO quarterly D&A has dropped by -$318.00 thousand (-65.30%).
- EVLO quarterly D&A is now -74.66% below its all-time high of $667.00 thousand, reached on June 30, 2018.
Performance
EVLO Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$1.56 M
-$318.00 K-16.92%
September 30, 2023
Summary
- As of February 8, 2025, EVLO TTM depreciation & amortization is $1.56 million, with the most recent change of -$318.00 thousand (-16.92%) on September 30, 2023.
- Over the past year, EVLO TTM D&A has dropped by -$514.00 thousand (-24.77%).
- EVLO TTM D&A is now -29.56% below its all-time high of $2.22 million, reached on December 31, 2021.
Performance
EVLO TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
EVLO Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.0% | -65.3% | -24.8% |
| 3 y3 years | +16.8% | -63.4% | -21.7% |
| 5 y5 years | +147.0% | -47.7% | -11.5% |
EVLO Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -7.0% | at low | -68.6% | at low | -29.6% | at low |
| 5 y | 5-year | -7.0% | +16.8% | -71.3% | at low | -29.6% | at low |
| alltime | all time | -7.0% | +316.2% | -74.7% | +3.7% | -29.6% | +857.7% |
Evelo Biosciences Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | $169.00 K(-60.1%) | $1.56 M(-16.9%) |
| Jun 2023 | - | $424.00 K(-4.7%) | $1.88 M(-5.5%) |
| Mar 2023 | - | $445.00 K(-14.9%) | $1.99 M(-3.5%) |
| Dec 2022 | $2.06 M(-7.0%) | $523.00 K(+7.4%) | $2.06 M(-0.7%) |
| Sep 2022 | - | $487.00 K(-8.6%) | $2.08 M(-4.6%) |
| Jun 2022 | - | $533.00 K(+3.1%) | $2.18 M(-1.0%) |
| Mar 2022 | - | $517.00 K(-3.9%) | $2.20 M(-0.9%) |
| Dec 2021 | $2.22 M(+9.4%) | $538.00 K(-8.5%) | $2.22 M(+0.2%) |
| Sep 2021 | - | $588.00 K(+6.1%) | $2.21 M(+6.0%) |
| Jun 2021 | - | $554.00 K(+3.4%) | $2.08 M(+0.7%) |
| Mar 2021 | - | $536.00 K(+0.6%) | $2.07 M(+2.2%) |
| Dec 2020 | $2.03 M | $533.00 K(+15.4%) | $2.03 M(+1.7%) |
| Sep 2020 | - | $462.00 K(-14.4%) | $1.99 M(+0.1%) |
| Jun 2020 | - | $540.00 K(+10.0%) | $1.99 M(+6.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $491.00 K(-1.8%) | $1.88 M(+6.6%) |
| Dec 2019 | $1.76 M(-8.8%) | $500.00 K(+8.5%) | $1.76 M(+8.6%) |
| Sep 2019 | - | $461.00 K(+7.7%) | $1.62 M(+9.3%) |
| Jun 2019 | - | $428.00 K(+14.1%) | $1.49 M(-13.9%) |
| Mar 2019 | - | $375.00 K(+4.2%) | $1.73 M(-10.9%) |
| Dec 2018 | $1.94 M(+132.0%) | $360.00 K(+11.5%) | $1.94 M(+6.3%) |
| Sep 2018 | - | $323.00 K(-51.6%) | $1.82 M(+4.8%) |
| Jun 2018 | - | $667.00 K(+14.0%) | $1.74 M(+38.2%) |
| Mar 2018 | - | $585.00 K(+138.8%) | $1.26 M(+50.6%) |
| Dec 2017 | $834.00 K(+68.5%) | $245.00 K(+2.5%) | $834.00 K(+41.6%) |
| Sep 2017 | - | $239.00 K(+27.8%) | $589.00 K(+68.3%) |
| Jun 2017 | - | $187.00 K(+14.7%) | $350.00 K(+114.7%) |
| Mar 2017 | - | $163.00 K | $163.00 K |
| Dec 2016 | $495.00 K | - | - |
FAQ
- What is Evelo Biosciences annual depreciation & amortization?
- What is the all time high annual D&A for Evelo Biosciences?
- What is Evelo Biosciences annual D&A year-on-year change?
- What is Evelo Biosciences quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Evelo Biosciences?
- What is Evelo Biosciences quarterly D&A year-on-year change?
- What is Evelo Biosciences TTM depreciation & amortization?
- What is the all time high TTM D&A for Evelo Biosciences?
- What is Evelo Biosciences TTM D&A year-on-year change?
What is Evelo Biosciences annual depreciation & amortization?
The current annual D&A of EVLO is $2.06 M
What is the all time high annual D&A for Evelo Biosciences?
Evelo Biosciences all-time high annual depreciation & amortization is $2.22 M
What is Evelo Biosciences annual D&A year-on-year change?
Over the past year, EVLO annual depreciation & amortization has changed by -$156.00 K (-7.04%)
What is Evelo Biosciences quarterly depreciation & amortization?
The current quarterly D&A of EVLO is $169.00 K
What is the all time high quarterly D&A for Evelo Biosciences?
Evelo Biosciences all-time high quarterly depreciation & amortization is $667.00 K
What is Evelo Biosciences quarterly D&A year-on-year change?
Over the past year, EVLO quarterly depreciation & amortization has changed by -$318.00 K (-65.30%)
What is Evelo Biosciences TTM depreciation & amortization?
The current TTM D&A of EVLO is $1.56 M
What is the all time high TTM D&A for Evelo Biosciences?
Evelo Biosciences all-time high TTM depreciation & amortization is $2.22 M
What is Evelo Biosciences TTM D&A year-on-year change?
Over the past year, EVLO TTM depreciation & amortization has changed by -$514.00 K (-24.77%)